首页 › 基金 › Column Group LLC › SRZN
Column Group LLC 对 SRZN 的持仓历史
SURROZEN INC · 医疗保健
Column Group LLC 在 Q2 2026 的 13F 申报中披露持有 SRZN(SURROZEN INC)1,916,950 股,市值约 US$49.7M,约占其申报组合的 56.46%,在其申报持仓中市值排名第 1 位。 Column Group LLC 最近 12 个申报季度中有 12 个季度披露了 SRZN 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Column Group LLC 对 SRZN 的持仓演变
Column Group LLC 于 Q3 2023 首次披露 SRZN 持仓:9,414,795 股(约 US$4.6M)。 该持仓在 Q1 2026 达到峰值 1,916,950 股,市值约 US$55.8M。 在 12 次申报中,Column Group LLC 4 次增持、2 次减持、5 次保持不变。 最近一期申报(Q2 2026)显示持股 1,916,950 股、市值约 US$49.7M。 持仓曾出现大幅变动:Q4 2023 减持约 93% (随后一个季度股价上涨 67%)、Q2 2024 增持约 31% (随后一个季度股价上涨 9%)、Q1 2025 增持约 85% (随后一个季度股价下跌 23%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 9.41M | $4.61M | 新进 |
| Q4 2023 | 627.65K | $5.90M | 减持 |
| Q1 2024 | 616.54K | $9.69M | 减持 |
| Q2 2024 | 810.09K | $8.87M | 增持 |
| Q3 2024 | 810.09K | $9.70M | 持有 |
| Q4 2024 | 810.09K | $11.62M | 持有 |
| Q1 2025 | 1.50M | $17.49M | 增持 |
| Q2 2025 | 1.50M | $13.41M | 持有 |
| Q3 2025 | 1.50M | $19.33M | 持有 |
| Q4 2025 | 1.85M | $41.84M | 增持 |
| Q1 2026 | 1.92M | $55.84M | 增持 |
| Q2 2026 | 1.92M | $49.74M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SRZN 与 13F 数据
SRZN(SURROZEN INC)属于医疗保健行业。我们追踪的基金中还有 51 只申报持有 SRZN,申报仓位最大的包括:TCG Crossover Management, LLC (US$38.2M), Boxer Capital Management, LLC (US$27.0M), Venrock Adviser, LLC (US$16.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SRZN 的基金
- TCG Crossover Management, LLC 1.47M 股 · $38.23M · Q2 2026
- Boxer Capital Management, LLC 1.11M 股 · $26.96M · Q2 2026
- Venrock Adviser, LLC 632.93K 股 · $16.42M · Q2 2026
- STEMPOINT CAPITAL LP 602.80K 股 · $13.79M · Q2 2026
- Spruce Street Capital LP 432.04K 股 · $11.21M · Q2 2026
- Kalehua Capital Management LLC 385.18K 股 · $10.00M · Q2 2026
- 5AM Venture Management, LLC 271.25K 股 · $7.04M · Q2 2026
- Vivo Capital, LLC 260.00K 股 · $6.75M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 173.40K 股 · $4.50M · Q2 2026
- REGENTS OF THE UNIVERSITY OF CALIFORNIA 133.21K 股 · $3.46M · Q2 2026
- Euclidean Capital LLC 87.70K 股 · $2.28M · Q2 2026
更多关于 Column Group LLC
常见问题
How long has Column Group LLC held SRZN?
Column Group LLC has disclosed SRZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Column Group LLC's current position in SRZN?
As of Q2 2026, Column Group LLC holds 1.92M shares of SRZN (SURROZEN INC), valued at $49.74M, representing 56.46% of its reported portfolio and ranking #1.
Has Column Group LLC been buying or selling SRZN?
In the latest 13F filing (Q2 2026), Column Group LLC held unchanged its position in SRZN. The position peaked in Q1 2026 at 1.92M shares.
Which other funds hold SRZN?
Other major institutional holders of SRZN include TCG Crossover Management, LLC, Boxer Capital Management, LLC, Venrock Adviser, LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.